Network pharmacology, molecular docking, and dynamics reveal the mechanisms of Hejie Shengfa Decoction against alopecia areata

The study explores the mechanisms of Hejie Shengfa Decoction (HSD), a Traditional Chinese Medicine, in treating alopecia areata (AA) through network pharmacology, molecular docking, and dynamics simulations. It identifies 96 active components and 985 potential target proteins, with 135 overlapping targets related to AA, including IL6, EGFR, and CASP3. Key components like stigmasterol and quercetin show significant interactions, promoting hair follicle regeneration through anti-inflammatory, antioxidant, and antiapoptotic activities. Despite its potential as an alternative treatment for AA, further toxicological studies are needed due to possible safety risks at high doses. The study provides a theoretical foundation for HSD's clinical application, though further validation is required.